965 / 1835
In-field cont
5y-EFS
OS
PET -ve
95%
83%
89%
PET +ve
71%
65%
73%
P<0.01
P=0.04
P=0.04
•
Better outcome than would be expected
•
Majority
early
stage
•
PET positivity defined by
IHP
criteria (~ DS 3-5)
•
Do these patients need SCT?
3y-LC
3y-PFS
Death
PET -ve
100%
97%
1 (2
nd
lymphoma)
PET +ve
90%
90%
1 (relapse)
Dorth
Halasz
COMMENTS